Sep 29, 2023
FDA
The new article addresses the FDA aspects related to the way information about risks and benefits associated with a clinical investigation should be communicated by a study sponsor to potential study participants. Table of Contents The United States Food and...
Read More
Sep 29, 2023
FDA
The article covers additional questions industry representatives may have with respect to informed consent and specific aspects associated thereto. In particular, the aspects addressed include the involvement of children and non-English speakers. Table of Contents...
Read More
Sep 27, 2023
FDA
The article highlights the aspects related to the rights and responsibilities of Institutional Review Boards in the context of informed consent. Table of Contents The Food and Drug Administration (FDA or the Agency), the US regulating authority in the sphere...
Read More
Sep 27, 2023
FDA
The article addresses the aspects related to the responsibilities of the parties involved in clinical investigations, namely, study sponsors and clinical investigators. Table of Contents The Food and Drug Administration (FDA or the Agency), the US regulating authority...
Read More
Sep 26, 2023
FDA
The new article highlights aspects related to the role and responsibilities of the US regulatory authority with respect to informed consent to be obtained before commencing clinical investigations involving human subjects. Table of Contents The Food and Drug...
Read More